Charles Ryhee
Stock Analyst at TD Cowen
(2.50)
# 2,399
Out of 5,056 analysts
17
Total ratings
60%
Success rate
10.95%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $80.26 | -0.32% | 5 | Nov 25, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $840.75 | -22.45% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $153.32 | +10.88% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $4.45 | +1,225.84% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $204.32 | -64.76% | 1 | Aug 16, 2022 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $7.47 | +2,416.73% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $15.10 | +92.05% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $80.26
Upside: -0.32%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $840.75
Upside: -22.45%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $153.32
Upside: +10.88%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $4.45
Upside: +1,225.84%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $204.32
Upside: -64.76%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $7.47
Upside: +2,416.73%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $15.10
Upside: +92.05%